U.S. Department of Health and Human Services

CRS 2024 (v24.0 and v24.1)

CRS VERSION 24.1

CRS Version 24.1 is expected to be released in August 2024.

View the CRS 2024 (v24.1) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 695 KB]
View the CRS 2024 (v24.1) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 801 KB]

Key enhancements included in CRS Version 24.1 are shown below.

Logic Changes to National GPRA/GPRAMA Report Measures

GPRA Developmental Measures:

Added the following GPRA Developmental topics:

Colorectal Cancer Screening (ages updated to 40-75)
Screening for Substance Use (added measures for alcohol and drug use risk screen)

Updated codes and/or logic in the following measures: Access to Dental Service; Caries Risk Assessment; Adolescent Immunizations; Cancer Screening: Mammogram Rates; Screening for Substance Use; Substance Use Disorder (SUD) in Women of Childbearing Age; Suicide Risk Assessment; Weight Assessment and Counseling for Nutrition and Physical Activity; HIV Screening; HIV Quality of Care; Hepatitis C Screening; Chlamydia Testing; Proportion of Days Covered by Medication Therapy; Concurrent Use of Opioids and Benzodiazepines.

Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes: (1) Removed measure with Active Diabetic Denominator. (2) Updated age range for patients with LDL-C greater than or equal to (≥) 190 mg/dL or diagnosis of familial hypercholesterolemia to 20 through 75. (3) Added patients ages 40 through 75 with a 10-year ASCVD risk score of greater than or equal to (≥) 20% to the denominator.
Diabetic Retinopathy: (1) Added HCPCS M1220, M1221 to Diabetic Retinal Exam definition. (2) Added LOINC code 103616-9 to BGP CREATININE LOINC CODES.
Cervical Cancer Screening: (1) Added CPT 0429U to HPV DNA definition. (2) Added LOINC codes 104170-6, 104132-6 to BGP HPV LOINC CODES. (3) Added LOINC code 104132-6 to BGP HPV PRIMARY LOINC CODES.
Cancer Screening: Mammogram Rates: Added HCPCS M1280 to bilateral mastectomy definition.
Colorectal Cancer Screening: Added HCPCS M1295 to total colectomy definition.
Alcohol Screening: Added CAGE-AID and TAPS-Alcohol Health Factors to alcohol screening and positive screen definitions.
Screening, Brief Intervention, and Referral to Treatment (SBIRT): Added CAGE-AID and TAPS-Alcohol Health Factors to alcohol screening and positive screen definitions.
Depression Screening: (1) Removed PHQ2 from depression screening definition. (2) Added Edinburgh Postnatal Depression Scale (EPDS) to depression screening definition.
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease: (1) Removed measure with Active Diabetic Denominator. (2) Updated age range for patients with LDL-C greater than or equal to (≥) 190 mg/dL or diagnosis of familial hypercholesterolemia to 20 through 75. (3) Added patients ages 40 through 75 with a 10-year ASCVD risk score of greater than or equal to (≥) 20% to the denominator.

CRS VERSION 24.0

CRS Version 24.0 was released on February 26, 2024.

View the CRS 2024 (v24.0) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 682 KB]
View the CRS 2024 (v24.0) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 782 KB]

Key enhancements included in CRS Version 24.0 are shown below.

Logic Changes to National GPRA/GPRAMA Report Measures
- GPRA Developmental Measures:
  - Added the following GPRA Developmental topics:
    - Influenza (updated time period to align with flu season)
    - Cancer Screening: Mammogram Rates (ages updated to 42-74)
  - Updated codes and/or logic in the following measures: Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes; Access to Dental Service; Dental Sealants; Topical Fluoride; Caries Risk Assessment; Adult Immunizations; Childhood Immunizations; Appropriate Medication Therapy after a Heart Attack; HIV Screening; HIV Quality of Care; Chlamydia Testing; Sexually Transmitted Infection (STI) Screening; Proportion of Days Covered by Medication Therapy; Concurrent Use of Opioids and Benzodiazepines.
- Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes: (1) Updated BGP PQA STATIN MEDS medication taxonomy. (2) Added POV ICD-10: Z51.5 to Palliative Care Definition.
- Access to Dental Service: Added D to prefix of RPMS/ADA CDT Dental Codes.
- Dental Sealants: Added D to prefix of RPMS/ADA CDT Dental Codes.
- Topical Fluoride: Added D to prefix of RPMS/ADA CDT Dental Codes.
- Influenza: Added CVX codes 123, 125-128, 160, 231 and CPT codes 90663, 90664, 90666, 90668 to Influenza definition.
- Adult Immunizations: Added CVX codes 123, 125-128, 160, 231 and CPT codes 90663, 90664, 90666, 90668 to Influenza definition.
- Childhood Immunizations: (1) Added CVX codes 215, 216 and CPT codes 90671, 90677 to Pneumococcal definition. (2) Removed POV 795.71 (Nonspecific serologic evidence of HIV) from HIV definition.
- Tobacco Use and Exposure Assessment: Added D to prefix of RPMS/ADA CDT Dental Codes.
- Tobacco Cessation: (1) Added D to prefix of RPMS/ADA CDT Dental Codes. (2) Changed Medication Taxonomy from BGP CMS Smoking cessation to BGP ECQM TOB CESSATION MEDS.
- Statin Therapy for the Prevention and Treatment of Cardiovascular Disease: (1) Updated BGP PQA STATIN MEDS medication taxonomy. (2) Added POV ICD-10: Z51.5 to Palliative Care Definition.
- HIV Screening: Removed POV 795.71 (Nonspecific serologic evidence of HIV) from HIV definition.

CRS 2024 Documentation